Quipt Home Medical Corp. (NASDAQ:QIPT) Shares Sold by Boston Partners

Boston Partners lowered its holdings in Quipt Home Medical Corp. (NASDAQ:QIPT - Free Report) by 61.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 218,820 shares of the company's stock after selling 352,479 shares during the period. Boston Partners owned about 0.51% of Quipt Home Medical worth $667,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. State Street Corp grew its stake in Quipt Home Medical by 1.0% during the 3rd quarter. State Street Corp now owns 621,388 shares of the company's stock worth $1,814,000 after buying an additional 6,317 shares during the last quarter. Jane Street Group LLC grew its position in shares of Quipt Home Medical by 28.5% during the third quarter. Jane Street Group LLC now owns 41,926 shares of the company's stock worth $122,000 after acquiring an additional 9,290 shares during the last quarter. JPMorgan Chase & Co. increased its holdings in shares of Quipt Home Medical by 68.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 30,403 shares of the company's stock worth $89,000 after acquiring an additional 12,383 shares during the period. Atom Investors LP acquired a new stake in shares of Quipt Home Medical in the 3rd quarter worth about $51,000. Finally, XTX Topco Ltd bought a new stake in Quipt Home Medical in the 3rd quarter valued at about $54,000. 42.85% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Quipt Home Medical

In other news, VP Patrick Dennis Gamble bought 17,000 shares of the business's stock in a transaction on Thursday, December 26th. The stock was purchased at an average cost of $2.45 per share, for a total transaction of $41,650.00. Following the completion of the transaction, the vice president now directly owns 40,057 shares of the company's stock, valued at approximately $98,139.65. This trade represents a 73.73 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 13.40% of the stock is currently owned by insiders.

Remove Ads

Quipt Home Medical Price Performance

NASDAQ QIPT remained flat at $2.28 on Wednesday. 73,850 shares of the company's stock traded hands, compared to its average volume of 194,351. The firm's 50 day simple moving average is $2.74 and its 200-day simple moving average is $2.74. Quipt Home Medical Corp. has a 1 year low of $2.23 and a 1 year high of $4.43. The stock has a market cap of $98.25 million, a PE ratio of -13.41 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.87 and a current ratio of 1.22.

Quipt Home Medical (NASDAQ:QIPT - Get Free Report) last issued its quarterly earnings data on Monday, February 10th. The company reported ($0.03) earnings per share (EPS) for the quarter. Quipt Home Medical had a negative return on equity of 6.70% and a negative net margin of 2.90%. On average, sell-side analysts anticipate that Quipt Home Medical Corp. will post -0.05 earnings per share for the current year.

About Quipt Home Medical

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.